Search results
Did Eli Lilly and Company (LLY) Achieve Its 10th Consecutive Year of Dividend Growth?
Insider Monkey via Yahoo Finance· 6 hours agoWe recently compiled a list of the 10 Dividend Zombies and Kings with Longest Dividend Payouts. In...
Weight-Loss Drugs Dangers Explained: Zepbound, Mounjaro Maker Warn Of Coming Counterfeit Lawsuit
Forbes· 4 days agoEli Lilly, the maker of Mounjaro and Zepbound, warned of the dangers of counterfeit drugs in an open...
Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
Zacks· 3 days agoNot only can price performance impact your portfolio, but it can help you compare investment results across sectors and industries as well. What if you'd invested in Eli & ...
Eli Lilly Files More Lawsuits at Sellers of Counterfeit Mounjaro, Zepbound
The Wall Street Journal· 3 days agoThe pharmaceutical company said it filed legal actions against med-spas, wellness centers and other...
Eli Lilly and Company (NYSE:LLY) Shares Sold by GSG Advisors LLC
ETF DAILY NEWS· 13 hours agoGSG Advisors LLC lessened its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 13.3% during the 1st quarter, according to its most ...
MJP Associates Inc. ADV Buys 604 Shares of Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 13 hours agoMJP Associates Inc. ADV grew its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 25.3% in the 1st quarter, according to its most recent filing ...
New weight loss drugs are coming, and they could burn more fat with fewer side effects
NBC NEWS· 9 hours agoThe next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 3 days agoSo, is Eli Lilly stock a buy right now? Eli Lilly Stock: Bullish Sales Growth In the first quarter, ...
Eli Lilly is cracking down on knock-off versions of its popular weight loss drug Zepbound
Quartz· 3 days agoEli Lilly said Thursday that it is taking legal action against six entities for selling unapproved...
Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea
Market Watch· 2 days agoEli Lilly & Co. said Friday that it has applied for U.S. regulatory approval to expand the use of...